These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15367380)

  • 1. Comparison of urinary excretion of phenolsulfonphthalein in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Wistar rats: involvement of primary active organic anion transporter.
    Itagaki S; Shimamoto S; Hirano T; Iseki K; Sugawara M; Nishimura S; Fujimoto M; Kobayashi M; Miyazaki K
    J Pharm Pharm Sci; 2004 Jul; 7(2):227-34. PubMed ID: 15367380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the disposition behavior of organic anions in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Long-Evans Agouti rats.
    Itagaki S; Sugawara M; Kobayashi M; Miyazaki K; Hirano T; Iseki K
    Drug Metab Pharmacokinet; 2004 Apr; 19(2):150-4. PubMed ID: 15499181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous porphyria of the Long-evans cinnamon rat: an animal model of Wilson's disease.
    Nakayama K; Takasawa A; Terai I; Okui T; Ohyama T; Tamura M
    Arch Biochem Biophys; 2000 Mar; 375(2):240-50. PubMed ID: 10700380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of phenolsulfonphthalein transport system in Long-Evans Cinnamon rats.
    Itagaki S; Chiba M; Kobayashi M; Sugawara M; Kobayashi M; Hirano T; Iseki K
    Biochim Biophys Acta; 2008 Jan; 1778(1):270-5. PubMed ID: 17976528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired hepatic copper homeostasis in Long-Evans Cinnamon rats: reduced biliary excretion of copper.
    Suzuki M; Aoki T
    Pediatr Res; 1994 May; 35(5):598-601. PubMed ID: 8065844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats.
    Fujiwara N; Iso H; Kitanaka N; Kitanaka J; Eguchi H; Ookawara T; Ozawa K; Shimoda S; Yoshihara D; Takemura M; Suzuki K
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1079-86. PubMed ID: 16970921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferrous and ferric iron accumulates in the brain of aged Long-Evans Cinnamon rats, an animal model of Wilson's disease.
    Kim JM; Ko SB; Kwon SJ; Kim HJ; Han MK; Kim DW; Cho SS; Jeon BS
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):143-7. PubMed ID: 15911138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal accumulation of porphyrin derivatives in the kidneys of Long-Evans Cinnamon rats, as evidenced by microspectrophotometry.
    Nakayama K; Takasawa A; Ohyama T; Tamura M
    Biochem Biophys Res Commun; 1998 Jan; 242(1):164-9. PubMed ID: 9439629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of disposition behavior and de-coppering effect of triethylenetetramine in animal model for Wilson's disease (Long-Evans Cinnamon rat) with normal Wistar rat.
    Iseki K; Kobayashi M; Ohba A; Miyazaki K; Li Y; Togashi Y; Takeichi N
    Biopharm Drug Dispos; 1992 May; 13(4):273-83. PubMed ID: 1600113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper balance and ceruloplasmin in chronic hepatitis in a Wilson disease animal model, LEC rats.
    Komatsu Y; Ogra Y; Suzuki KT
    Arch Toxicol; 2002 Sep; 76(9):502-8. PubMed ID: 12242607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between Zn and Cu in LEC rats, an animal model of Wilson's disease.
    Santon A; Giannetto S; Sturniolo GC; Medici V; D'Incà R; Irato P; Albergoni V
    Histochem Cell Biol; 2002 Mar; 117(3):275-81. PubMed ID: 11914925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease.
    Levy E; Brunet S; Alvarez F; Seidman E; Bouchard G; Escobar E; Martin S
    Life Sci; 2007 Mar; 80(16):1472-83. PubMed ID: 17303181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of tetrathiomolybdate on hepatic dysfunction occurring naturally in Long-Evans Cinnamon (LEC) rats: a bona fide animal model for Wilson's disease.
    Sugawara N; Lai YR; Sugawara C
    Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):177-87. PubMed ID: 10461684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Malate decreases renal content of α-ketoglutarate, a driving force of organic anion transporters OAT1 and OAT3, resulting in inhibited tubular secretion of phenolsulfonphthalein, in rats.
    Uwai Y; Kawasaki T; Nabekura T
    Biopharm Drug Dispos; 2017 Nov; 38(8):479-485. PubMed ID: 28744858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-biochemical study of experimental renal injuries in rats. 3. Relations between serum half-life of phenolsulfonphthalein and renal injuries].
    Furuhama K; Yamada M; Onodera T
    Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):507-18. PubMed ID: 6225713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal secretion of phenolsulfonphthalein: analysis of its vectorial transport in normal and mutant analbuminemic rats.
    Inoue M; Koyama H; Nagase S; Morino Y
    J Lab Clin Med; 1985 Apr; 105(4):484-8. PubMed ID: 3981059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selective cyclooxygenase-2 inhibitor lumiracoxib on phenolsulfonphthalein disposition in rats.
    Honjo H; Uwai Y; Nabekura T
    Drug Metabol Drug Interact; 2014; 29(3):203-6. PubMed ID: 24870608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major role of organic anion transporters in the uptake of phenolsulfonphthalein in the kidney.
    Itagaki S; Sugawara M; Kobayashi M; Nishimura S; Fujimoto M; Miyazaki K; Iseki K
    Eur J Pharmacol; 2003 Aug; 475(1-3):85-92. PubMed ID: 12954363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.
    Robertson EE; Rankin GO
    Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion.
    Shin YJ; Lee JH; Oh JH; Lee YJ
    J Appl Toxicol; 2013 Jun; 33(6):511-5. PubMed ID: 22161506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.